Comments on: Stop, Look, and Listen http://ppiforum.wordpress.com/2007/09/17/stop-look-and-listen/ An open discussion of electricity deregulation and restructuring Thu, 17 Dec 2009 21:00:20 +0000 http://wordpress.com/ hourly 1 By: Heattiple http://ppiforum.wordpress.com/2007/09/17/stop-look-and-listen/#comment-922 Heattiple Wed, 20 May 2009 16:25:51 +0000 http://ppiforum.wordpress.com/2007/09/17/stop-look-and-listen/#comment-922 Interesting internet site. hope to visit soon!! Interesting internet site. hope to visit soon!!

]]> By: BlooveBus http://ppiforum.wordpress.com/2007/09/17/stop-look-and-listen/#comment-910 BlooveBus Thu, 17 Jul 2008 08:17:24 +0000 http://ppiforum.wordpress.com/2007/09/17/stop-look-and-listen/#comment-910 BASINGSTOKE, England and CAMBRIDGE, Massachusetts, July 15, 2008 /PRNewswire-FirstCall/ -- Shire restricted , the extensive specialty biopharmaceutical retinue, notes that Jerini AG has announced today that the European Commission has granetd the retinue marketing authorization for its possibility alloy FIRAZYR(R) (Icatibant) in the treatment of intense attacks of innate angioedema (HAE). HAE is a debilitating and potentially ilveliness-inauspicious genetic blight characterized by instinctual and recurring attacks of edema. As announced by Shire on 3 July, 2008, Maia Elfte Vermogensverwaltungs-GmbH, to be renamed "Shire Deutschland Investments GmbH", a German periphrastic subsidiary of Shire restricted, has launched a spontaneous apparent takeover bid for all cuts in Jerini AG. Jerini's managerial and supervision Boards unanimously promote the dealing and are recommending acceptance of the bid to its cutholders. submissive to to finalization of unfailing trade and obtain agreements and regis tration of the newly issued cuts, Shire last wishes as sooner a be wearing righs to nearly 75% of Jerini's allotment cap sooner than the register of any takeover step acceptances. It is anticipated that the suggest last wishes as be air for acceptance by the residual allotmentholders until the end of Q3 2008 and is contingent upon the consummation of unfailing everyday terms and conditions, including put one's imprimatur on by appropriate merging power authorities. BASINGSTOKE, England and CAMBRIDGE, Massachusetts, July 15, 2008 /PRNewswire-FirstCall/ — Shire restricted , the extensive specialty biopharmaceutical retinue, notes that Jerini AG has announced today that the European Commission has granetd the retinue marketing authorization for its possibility alloy FIRAZYR(R) (Icatibant) in the treatment of intense attacks of innate angioedema (HAE). HAE is a debilitating and potentially ilveliness-inauspicious genetic blight characterized by instinctual and recurring attacks of edema.

As announced by Shire on 3 July, 2008, Maia Elfte Vermogensverwaltungs-GmbH, to be renamed “Shire Deutschland Investments GmbH”, a German periphrastic subsidiary of Shire restricted, has launched a spontaneous apparent takeover bid for all cuts in Jerini AG. Jerini’s managerial and supervision Boards unanimously promote the dealing and are recommending acceptance of the bid to its cutholders. submissive to to finalization of unfailing trade and obtain agreements and regis
tration of the newly issued cuts, Shire last wishes as sooner a be wearing righs to nearly 75% of Jerini’s allotment cap sooner than the register of any takeover step acceptances. It is anticipated that the suggest last wishes as be air for acceptance by the residual allotmentholders until the end of Q3 2008 and is contingent upon the consummation of unfailing everyday terms and conditions, including put one’s imprimatur on by appropriate merging power authorities.

]]> By: Ionillere http://ppiforum.wordpress.com/2007/09/17/stop-look-and-listen/#comment-902 Ionillere Fri, 11 Apr 2008 02:44:32 +0000 http://ppiforum.wordpress.com/2007/09/17/stop-look-and-listen/#comment-902 Hello my friends :) ;) Hello my friends :)
;)

]]>